{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:59:22Z","timestamp":1649098762376},"reference-count":0,"publisher":"BENTHAM SCIENCE PUBLISHERS","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,25]]},"DOI":"10.2174\/9781608057474113010008","type":"book-chapter","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T15:29:38Z","timestamp":1376407778000},"page":"81-97","source":"Crossref","is-referenced-by-count":0,"title":["Risks and Benefits Associated with High Therapeutic Doses of Erythropoiesis Stimulating Agents"],"prefix":"10.2174","member":"965","container-title":["Frontiers in Drug Discovery: Erythropoietic Stimulating Agents"],"original-title":[],"deposited":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T15:29:46Z","timestamp":1376407786000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/node\/113547"}},"subtitle":[],"editor":[{"given":"Sandra","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"El\u00edsio","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Fl\u00e1vio","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Alice","family":"Santos-Silva","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2174\/9781608057474113010008","relation":{},"subject":[],"published":{"date-parts":[[2013,7,25]]}}}